Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment-Reference-Cited by-同舟云学术

Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment

Published:2017-04-18 Issue:5 Volume:101 Page:634-645
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Yuraszeck T¹,Kasichayanula S¹,Benjamin JE²

Affiliation:

1. Clinical Pharmacology, Modeling, and Simulation; Amgen Inc.; Thousand Oaks California USA

2. Global Development, Oncology; Amgen Inc.; Thousand Oaks California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference88 articles.

1. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy;Khalil;Nat. Rev. Clin. Oncol.,2016

2. Immunotherapy and novel combinations in oncology: current landscape, challenges, and opportunities;Morrissey;Clin. Transl. Sci.,2016

3. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893;Coley;Clin. Orthopaed. Relat. Res.,1991

4. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas;McCarthy;Iowa Orthopaed. J.,2006

5. Ueber den jetzigen Stand der Karzinomforschung;Ehrlich;Ned. Tijdschr. Geneeskd,1909

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific T-Cell Engagers (BiTEs) in Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

3. Effectors of the Future: Universal Chimeric Antigen Receptor;Transfusion Medicine and Hemotherapy;2024-07-15

4. Eficácia e Segurança do Blinatumomabe no Tratamento da Leucemia Linfoblástica Aguda: Revisão Sistemática da Literatura;Revista Brasileira de Cancerologia;2024-04-22

5. Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives;Frontiers in Oncology;2024-04-10